April 2025 continues the strong momentum in the femtech space, with a wave of startups raising capital to tackle fertility, diagnostics, maternal health, and more. From AI-powered male fertility tools to progesterone delivery devices for miscarriage prevention, this month’s funding news highlights just how broad, and essential, the femtech landscape has become.
With major rounds like ByHeart’s $72M and Future Family’s $400M financing initiative, femtech is clearly stepping into a new era of impact and scalability. Here's a breakdown of the most notable femtech funding rounds from this month, with a spotlight on the bold founders behind them.
→Founded by: Émeline Hahn, Julien Guay, Allan, and Paul Grandemange
Fizimed is a French healthtech company focused on pelvic floor rehabilitation through connected medical devices. With this new funding, the company aims to accelerate its international expansion and bring its innovative solutions to more women globally.
→Founded by: Dr. Lara Zibner and Thang Vo-Ta
Calla Lily is developing a progesterone delivery device designed to prevent miscarriage. The £1M in funding will support upcoming clinical trials, helping to address a critical gap in early pregnancy care.
→Founded by: Ron Belldegrun and Mia Funt
ByHeart is a next-generation baby formula company that focuses on clean-label nutrition and clinical rigor. This massive $72M raise will help scale manufacturing and expand distribution as demand for infant nutrition alternatives continues to rise.
→Founded by: Claire Tomkins
Future Family is on a mission to make fertility treatments more affordable and accessible. Their $400M financing program will provide personalized plans to patients, lowering the barrier to high-quality fertility care.
→Founded by: Lauren Makler and Halle Tecco
Cofertility offers a platform that supports egg freezing and donation with an inclusive and accessible model. The Series A funding will help the team expand operations and further develop their tech-driven fertility services.
→Founded by: Michel Bielecki, Jeyla Sadikova, and Loup Cordey
illumicell AI is creating a portable, AI-powered diagnostic platform for real-time male fertility testing. Their innovative device is designed to make fertility analysis faster, more accurate, and accessible beyond clinical settings.
→Founded by: Mili Kale and Maya Kale
Moom Health is a women’s health supplement brand based in Southeast Asia, blending Ayurvedic tradition with modern science. This round will help them scale their product line and expand into new markets.
→Founded by: Professor Melina Schuh and Dr. Agata Zielinska
Ovo Labs is tackling IVF success rates for women over 35 with cutting-edge reproductive science. Their £4M round supports new advancements aimed at increasing positive fertility outcomes through age-specific interventions.
→Founded by: Estelle Giraud and Ryan Nabat
Trellis Health is building an AI-driven platform that gives women proactive control over their health data, starting with pregnancy and extending into overall wellness. The company just emerged from stealth with this early round to build its MVP.
→Founded by: Brendan Staunton, Dr. Emma Carr, and Geoffrey Cundiff
Amara Therapeutics is developing digital therapeutics for pelvic health, with their current focus on treating overactive bladder. The new funding will support US clinical trials and regulatory approval pathways.
Femtech (female technology) refers to software, diagnostics, products, and services that use technology to support and improve women’s health. This includes everything from reproductive health and fertility solutions to menopause care, maternal health, and period products. With an increasing number of startups and investors recognizing the importance of women's health solutions, femtech is becoming one of the fastest-growing sectors in healthcare.